MetLife Investment Management LLC Sells 509 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

MetLife Investment Management LLC decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 1.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 28,501 shares of the biopharmaceutical company’s stock after selling 509 shares during the quarter. MetLife Investment Management LLC’s holdings in Regeneron Pharmaceuticals were worth $20,563,000 at the end […]

Related Keywords

Canada ,Marion Mccourt ,Arthurf Ryan ,Quarter For Regeneron Pharmaceuticals ,Jpmorgan Chase Co ,Nasdaq ,Wells Fargo Company ,Ritter Daniher Financial Advisory ,Minichmacgregor Wealth Management ,News Ratings For Regeneron Pharmaceuticals Daily ,Barclays ,Metlife Investment Management ,Royal Bank ,Regeneron Pharmaceuticals Stock Performance ,Regeneron Pharmaceuticals Inc ,Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Company Profile ,Securities Exchange Commission ,Trifecta Capital Advisors ,Steward Financial Group ,Jefferies Financial Group ,Insider Transactions At Regeneron Pharmaceuticals ,Get Rating ,Life Investment Management ,Financial Group ,Capital Advisors ,Daniher Financial Advisory ,Director Arthur ,Exchange Commission ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,